Investment in Viet-Japan Medical Bridge Co. to Enhance Healthcare Supply in Vietnam

Strategic Investment in Viet-Japan Medical Bridge Co.

Recently, our company has entered into a capital investment agreement with Mr. Kazuhiko Dan, the representative of Viet-Japan Medical Bridge Investment Co., Ltd. (VJMB), which is located in Hanoi, Vietnam. This new venture aligns with our ongoing commitment to enhancing healthcare services in Vietnam.

Background and Objectives

In November 2013, we established a joint venture with a local Vietnamese company, CONG TY CO PHAN DUOC PHAM TRUNG UONG CODUPHA (Codupha), creating Alfresa Codupha Healthcare Vietnam Co., Ltd. (Alcopha), which operates from Ho Chi Minh City. One of our primary activities has been to import medical devices and materials from Japan, distributing these vital supplies to medical institutions and pharmacies throughout Vietnam.

As part of our medium-term management plan titled “Vision2032 Stage 2,” we have emphasized the evolution of our Asian business strategy, particularly focusing on the Vietnamese market for pharmaceutical development.

Mr. Kazuhiko Dan, an ophthalmologist, plays a crucial role in supporting eye care in Vietnam. He established VJMB in 2017 and has obtained a pharmaceutical import license from Vietnam's Ministry of Health. VJMB is currently preparing for the sale of glaucoma eye drops from a Japanese pharmaceutical company and expects to launch these products soon.

Our capital participation in VJMB will leverage the sales network and partnerships we've developed with healthcare facilities and professionals in Vietnam. This strategic move will enable us to offer a comprehensive range of healthcare-related products, including medical devices, materials, and pharmaceuticals, tailored to the local healthcare needs. Together with VJMB, we are committed to expanding our operations in the Vietnamese market while continuing to contribute positively to the quality of local medical services through the supply of healthcare products.

Overview of VJMB (As of September 10, 2025)

VJMB has been making significant inroads into the Vietnamese healthcare market, focusing on the specifics needed for local medical contexts. With Vietnam’s currency exchange rate calculated at VND = 0.005584 JPY as of September 10, 2025, our investment aims to enhance the accessibility and quality of healthcare in the region.

Future Outlook

Currently, we anticipate only a minor impact on our performance for the fiscal year ending March 2026 from this investment. However, we firmly believe that, in the medium to long term, it will contribute to the enhancement of our corporate value as a group. We will communicate any significant developments regarding this investment as they arise.

In conclusion, our partnership with VJMB is poised to foster significant improvements in Vietnam's healthcare landscape, aligning with our vision for a healthier future in the region.